Micro
Aftermath
Active
नोवो नॉर्डिस्क द्वारा वेगोवी की उच्च खुराक की एफडीए मंजूरी
Activity declining — narrative losing relevance.
स्कोर
0.3
गति
▲ 0.0
लेख
14
स्रोत
3
Sentiment Timeline
Event Timeline
अप्र 02, 2026
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
Bullish
अप्र 01, 2026
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England
Bullish
मा 31, 2026
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries …
Neutral
संबंधित लेख
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England
Nasdaq
·
अप्र 01, 2026
Could This New Approval Be a Turning Point For Novo Nordisk?
Nasdaq
·
अप्र 01, 2026
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to …
CNBC
·
मा 23, 2026
This Hims & Hers Move Could Destroy Competitors
Nasdaq
·
मा 21, 2026
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?
Nasdaq
·
मा 20, 2026
Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and other weight-loss drugs.
Yahoo Finance
·
मा 20, 2026
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to …
CNBC
·
मा 19, 2026
समयरेखा
पहली बार देखामा 19, 2026
अंतिम अपडेटमा 19, 2026